|Articles|April 1, 1999

A Multidisciplined Approach to Improving the Treatment of Allergic Rhinitis in the Managed Care Popu
Volume 5
Issue 4 Suppl

The Role of the ECHO Model in Outcomes Research and Clinical Practice Improvement

Author(s)Margaret J. Gunter, PhD

Download PDF: The Role of the ECHO Model in Outcomes Research and Clinical Practice Improvement

Articles in this issue

over 27 years ago

Article

Participating Faculty

over 27 years ago

Article

Selected Abstracts

over 27 years ago

Article

Bibliography

over 27 years ago

Article

Economic Outcomes of a Targeted Intervention Program: The Costs of Treating Allergic Rhinitis Patients

over 27 years ago

Article

Effect of Fexofenadine HC1 on Quality of Life and Work, Classroom, and Daily Activity Impairment in Patients with Seasonal Allergic Rhinitis

over 27 years ago

Article

Diagnosis and Treatment of Allergic Rhinitis: Primary Care in an Integrated Health System Setting

over 27 years ago

Article

CME Quiz

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

ByChristopher Scannell, MD, PhD,John A. Romley, PhD,Rebecca Myerson, PhD,Dana Goldman, PhD,Dima Mazen Qato, PharmD, PhD, MPH

July 9th 2026

The Role of the ECHO Model in Outcomes Research and Clinical Practice Improvement

Articles in this issue

Related Content

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Trending on AJMC

Trump Announces Timeline for 100% Generic Drug Tariffs Beginning in 2028, 200% in 2029

Fifth Death Confirmed in NYC Legionnaires' Outbreak

Pirtobrutinib Plus Venetoclax-Rituximab Cuts CLL Progression 45%

Small Workflow Changes Close Big Gaps in CKM Screening

Obesity, Insulin Resistance, and the Silent Progression of MASH: A Hepatologist's Perspective